Lamdong Pharmaceutical Joint Stock Company reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was VND 187,414.7 million compared to VND 161,902.37 million a year ago. Net loss was VND 38,891.2 million compared to net income of VND 37,870.25 million a year ago.

Basic loss per share from continuing operations was VND 3,062 compared to basic earnings per share from continuing operations of VND 2,981 a year ago. Diluted loss per share from continuing operations was VND 3,062 compared to diluted earnings per share from continuing operations of VND 2,981 a year ago.